TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Starpharma Holdings Limited ( (AU:SPL) ) just unveiled an update.
Starpharma Holdings Limited announced the cessation of 716,375 performance rights due to unmet conditions, impacting its issued capital structure. This development may affect stakeholders’ perceptions of the company’s operational progress and could influence its market positioning by highlighting challenges in meeting performance targets.
More about Starpharma Holdings Limited
Starpharma Holdings Limited operates within the pharmaceutical industry, focusing on the development of innovative medical solutions, particularly in the area of dendrimer-based products. The company is known for its work in drug delivery and development of novel therapeutics with a market focus on enhancing the performance of pharmaceuticals.
YTD Price Performance: -17.27%
Average Trading Volume: 384,930
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$38.06M
See more data about SPL stock on TipRanks’ Stock Analysis page.